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Abstract Acetyl-CoA carboxylase and HMGCoA reductase 
are inactivated by the same AMP-activated protein kinase and 
are activated by type-2A protein phosphatase. To determine 
whether the same species of protein phosphatase-2A were 
involved, we studied the interconversion of acetyl-CoA carbox-
ylase and HMGCoA reductase in isolated rat hepatocytes. We 
show that (i) these enzymes are differently regulated in 
hepatocytes and (ii) the species of type-2A protein phosphatase 
involved in their activation are different and can be separated by 
anion-exchange chromatography. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Acetyl-CoA carboxylase (ACC), a regulatory enzyme of 
lipogenesis, is controlled by phosphorylation/dephosphoryla-
tion of several Ser residues [1]. In hepatocytes, inactivation of 
A C C occurs in response to glucagon and results from the 
phosphorylation of Ser79 by the AMP-activated protein kinase 
(AMPK) [2]. In adipocytes, activation of A C C follows insulin 
treatment and was reported to be mediated by the phospho-
rylation of an as yet unidentified site located within a tryptic 
peptide called the 'I-peptide' [3]. Activation of A C C was also 
observed in hepatocytes treated with Na + -cot ranspor ted ami-
no acids, such as glutamine and proline [4]. The activation of 
A C C in glutamine-treated hepatocytes was proposed to be 
mediated by glutamate [5], which accumulates in these cells 
[6,7], and stimulates a protein phosphatase that was recently 
identified as a new species of hepatic type-2A protein phos-
phatase (PP-2A) [8]. This glutamate-activated protein phos-
phatase (GAPP) reverses the in vitro inactivation of A C C 
by A M P K [8]. 
Another well-known substrate of A M P K is hydroxymethyl-
glutaryl-CoA ( H M G C o A ) reductase [1], a regulatory enzyme 
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in cholesterol synthesis that is anchored in the endoplasmic 
reticulum membrane. Its C-terminal domain contains the cat-
alytic site and can be released as a soluble, active fragment of 
53 k D a by proteolysis [9]. Phosphorylation by A M P K of 
Ser871 in the C-terminal domain inactivates H M G C o A reduc-
tase [10]. Incubation of hepatocytes with okadaic acid, a po-
tent inhibitor of type-1 protein phosphatases (PP-1) and 
PP-2A [11], completely inactivated H M G C o A reductase with-
in a few minutes [12]. PP-2A contributes the major proport ion 
of H M G C o A reductase phosphatase in intact cells, because 
PP-1 accounts for only a few percent of H M G C o A reductase 
phosphatase in liver extracts [13]. 
Therefore, liver H M G C o A reductase and A C C appear to 
be covalently regulated in a similar way. Both of them are 
inactivated by A M P K and activated by type-2A phospha-
tases. In addition, both activities follow a diurnal rhythm 
with a peak of activity in the middle of the dark period, 
when rats are eating [14,15]. For ACC, the diurnal variation 
results from modification in the phosphorylation state rather 
than from changes in enzyme content [14], whereas for 
H M G C o A reductase, changes in both the amount and the 
phosphorylation state are involved [15]. The variations in 
the phosphorylation state of both enzymes during a 24-h pe-
riod do not result from changes in A M P K activity and could 
therefore be mediated by variations in the activity of PP-2A 
[14]. Glutamine could stimulate PP-2A when the rats start 
eating and, thereby, activate H M G C o A reductase and ACC. 
In this work, we tested whether incubation of hepatocytes 
with glutamine could activate H M G C o A reductase, as well 
as ACC. 
2. Materials and methods 
2.1. Material 
Phosphorylase b and phosphorylase kinase were from Sigma and 
radiochemicals from Amersham. The synthetic SAMS-peptide 
(HMRSAMSGLHLVKRR), a substrate for AMPK [16], was synthe-
tized by V. Feytons (Leuven, Belgium) [8]. ACC was purified to ho-
mogeneity from livers of re-fed rats [5]. AMPK was purified as far as 
the Blue Sepharose step [17]. The purified C-terminal catalytic domain 
of HMGCoA reductase was purified on Ni2+-agarose [18] and was 
phosphorylated by [y-32P]ATP in the presence of AMPK as described 
[19]. Phosphorylase b was phosphorylated by [y-32P]ATP in the pres-
ence of phosphorylase kinase [20]. 
2.2. Cell isolation and incubation 
Male Wistar rats (200-300 g) were maintained on a regime of room 
light from 22:00 to 10:00 h and darkness from 10:00 h to 22:00 h. 
Hepatocytes [21] were prepared at 10 h, i.e. at the beginning of the 
dark period when the animals start eating. This time was chosen 
because HMGCoA reductase should be phosphorylated and thus a 
better substrate for protein phosphatases [15]. Cells were incubated at 
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30 mg wet weight/ml of incubation medium in Krebs-Henseleit bicar-
bonate buffer [22] in equilibrium with a gas phase containing O2/CO2 
(95:5) and supplemented with 10 mM glucose. 
2.3. Measurement of enzyme activities 
ACC activity was measured in digitonin-permeabilized hepatocytes 
in the presence of 0.5 mM Mg-citrate (method 2 in [5]). AMPK was 
measured by phosphorylation of the SAMS peptide in the presence of 
0.2 mM AMP in 0-6% polyethylene glycol fractions made from cell 
homogenates [23]. HMGCoA reductase activity was measured in dig-
itonin-permeabilized hepatocytes [24]. Enzyme activity is expressed as 
units (U), i.e. |xmol of substrate consumed per minute under the assay 
conditions. The values shown are the means ± SEM for the given 
number of different preparations of hepatocytes. The statistical sig-
nificance of differences was calculated by Student's t test (paired data). 
2.4. Separation and measurement of GAPP, HMGCoA reductase 
phosphatase and phosphorylase phosphatase 
A liver cytosolic fraction was fractionated on a DEAE-Sephadex-
A50 as described [8]. The ACC phosphatase activity of GAPP was 
measured by the glutamate-stimulate activation at 37°C of 0.15— 
0.50 uM purified ACC [8], which was assayed (method 1 in [5]) in 
the presence of 0.5 mM Mg-citrate. One unit of ACC phosphatase is 
defined as the amount that generates 1 unit of ACC/min under the 
specified conditions. 
The HMGCoA reductase phosphatase and phosphorylase phospha-
tase activities were determined at 30°C from the linear rate of dephos-
phorylation of the 32P-labelled substrates at a final concentration of 
30 ug/ml or 10 (iM, respectively [19,20]. The released [32P]Pi was 
measured by liquid scintillation after precipitation by 10% trichloro-
acetic acid of the remaining substrates together with 3 mg/ml albumin. 
One unit of HMGCoA reductase phosphatase or phosphorylase phos-
phatase produces 1 pmol or 1 urnol of phosphate/min under the 
specified conditions, respectively. 
3. Results 
3.1. Effect of glutamine on HMGCoA reductase and 
ACC activity in hepatocytes 
In hepatocytes prepared from rats at the end of the light 
period, the expressed HMGCoA reductase activity was only 
about 10% of that in cells prepared from rats taken in the 
middle of the dark period, as reported previously [15]. Incu-
bation of the cells (prepared at the end of the light period) for 
60 min did not result in a significant increase in HMGCoA 
reductase activity (Fig. 1A). Incubation with 10 mM gluta-
mine did not modify HMGCoA reductase activity (Fig. 1A), 
whereas it activated (3-fold) ACC in the same experiments 
(Fig. IB). Hepatocytes were also incubated in the presence 
of 1 mM AICAriboside to activate AMPK. AICAriboside is 
taken up by the cells and converted into ZMP, which stimu-
lates AMPK because its structure is similar to that of AMP 
[25-27]. As expected, both HMGCoA reductase and ACC 
were almost completely inactivated within 15 min (Fig. 1), 
thus confirming that AMPK indeed inactivates both enzymes 
in intact cells. 
3.2. Effect of glutamine on HMGCoA reductase, AMPK and 
ACC activity in hepatocytes preincubated without oxygen 
Anoxia is known to deplete ATP and to increase AMP in 
hepatocytes [28]. We tested whether anoxia could inactivate 
HMGCoA reductase and allow reactivation by glutamine to 
take place in a subsequent incubation in the presence of oxy-
gen. After a 30-min incubation without oxygen, AMPK activ-
ity was 0.46 ± 0.20 mU/mg of protein (100% of activity in Fig. 
2A) and HMGCoA reductase activity was not significantly 
decreased (7.0±0.9 to 5.511.1 mU/g of cells). During the 
following reoxygenation, AMPK activity decreased by about 
60% within 15 min (Fig. 2A) and a concomitant increase in 
HMGCoA reductase activity was observed (Fig. 2B). Incuba-
tion with 10 mM glutamine did not affect AMPK inactivation 
(Fig. 2A), nor the concomitant activation of HMGCoA re-
ductase (Fig. 2B). 
As for HMGCoA reductase, the 30-min incubation without 
oxygen did not inactivate ACC (10.712.1 mU/g of cells with 
oxygen vs. 11.612.2 mU/g of cells without oxygen). This lack 
of inactivation might be related to the well known anoxia-
induced depletion of ATP. By contrast with HMGCoA reduc-
tase, ACC activation was not observed upon reoxygenation 
alone but required the presence of glutamine (Fig. 2C). 
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Fig. 1. Time-course of the effect of glutamine or AICAriboside on HMGCoA reductase (A) or ACC (B) activity in hepatocytes. Hepatocytes 
were incubated for 15 min in the presence of 10 mM glucose, and then in the absence (o) or presence of 10 mM glutamine ( • ) or 1 mM 
AICAriboside (■) for the indicated times. The results are the means ± S.E.M. for three (A) or five (B) different cellular preparations. *Signifi-
cantly different (P < 0.05) from the respective control value. 
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Fig. 2. Time-course of the effect of glutamine on AMPK (A), HMGCoA reductase (B) or ACC (C) activity in hepatocytes during reoxygena-
tion. Hepatocytes were incubated for 30 min in the presence of 10 mM glucose but in the absence of oxygen [28]. Cells were then reoxygenated 
and further incubated in the absence (o) or presence (•) of 10 mM glutamine for the indicated times. The results are the means ±S.E.M. for 
three (A), six (B) or five (C) different cellular preparations. * Significantly different (P<0.05) from the value at 0 min. Significantly different 
(P £ 0.05) from the respective control value. 
3.3. Separation of HMGCoA reductase phosphatase from 
GAPP by chromatography on DEAE-Sephadex-A50 
No effect of glutamine on HMGCoA reductase activity was 
detected in hepatocytes. This suggests that glutamate does not 
stimulate HMGCoA reductase activation or, alternatively, 
that HMGCoA reductase phosphatase differs from GAPP. 
Indeed, several trimeric forms of PP-2A have been identified. 
They have a common core structure consisting of a 36-38 
kDa catalytic subunit (PP-2Ac) and a 61-65 kDa regulatory 
subunit (subunit A). This dimeric species ( P P - 2 A D ) can also 
associate with a third (B) subunit. The trimeric forms of 
PP-2A are named according to the size of their B subunit 
[29], e.g. PP-2AT54, PP-2AT55, PP-2AT72, PP-2AT74 in cardiac 
or skeletal muscle. This B subunit is thought to regulate the 
activity and substrate specificity of type-2A protein phos-
phatases [30]. In liver, two species of PP-2A were first de-
scribed and were named PP-2Ai and PP-2A2 [31]. PP-2A2 
was identified as PP-2Arj [32], whereas PP-2Ax has a trimeric 
structure and was tentatively identified as the hepatic homolog 
of PP-2AT55 [33]. GAPP is a newly discovered hepatic type-2A 
phosphatase with a relative mass of 285 000 which suggests a 
trimeric structure [8]. 
If the HMGCoA reductase phosphatase and GAPP are in-
deed different type-2A protein phosphatases, they might be 
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Fig. 3. Elution profile of HMGCoA reductase phosphatase, GAPP and phosphorylase phosphatase activities from DEAE-Sephadex-A50. A 
liver cytosolic fraction was applied on a DEAE-Sephadex-A50 column, as detailed in [9]. The fractions were assayed for HMGCoA reductase 
phosphatase (o), GAPP (#), or protamine-stimulated phosphorylase phosphatase (■) activity. I and II refer to the two peaks of HMGCoA 
reductase phosphatase. 
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separated by chromatography. A cytosol from rat liver was 
therefore fractionated by chromatography on DEAE-Sepha-
dex-A50. Two peaks of H M G C o A reductase phosphatase 
(peaks I and II in Fig. 3), as measured by the dephosphory-
lation of the catalytic domain of H M G C o A reductase, were 
detected. This is in agreement with previous observations 
[34,35]. The fractions were also tested for their ability to de-
phosphorylate phosphorylase a in the presence of protamine, 
a well known stimulator of the phosphorylase phosphatase 
activity of PP-2A [36]. Two peaks of activity corresponding 
to PP-2Ai and PP-2A2 were detected (Fig. 3). As observed by 
others [34], the peak of PP-2A! was eluted immediately after 
the peak I of H M G C o A reductase phosphatase al though the 
elution profile of these two protein phosphatases were over-
lapping (Fig. 3). PP-2A2 co-eluted with the peak II of 
H M G C o A reductase phosphatase. G A P P was eluted as a sin-
gle peak between PP-2Ai and PP-2A2 as already observed [8] 
and between the two peaks of H M G C o A reductase phospha-
tase (Fig. 3). 
4. Discussion 
In isolated hepatocytes incubated in the presence of gluta-
mine to stimulate G A P P , no change in H M G C o A reductase 
activity was detected, whereas a 3-fold activation of A C C was 
observed within the same experiments. Reoxygenation of 
hepatocytes following a period of anoxia elicited an activation 
of H M G C o A reductase that was not influenced by glutamine 
addition. This suggests that hepatocytes contain an active 
H M G C o A reductase phosphatase that differs from GAPP. 
These two protein phosphatases were indeed found to be sep-
arated by chromatography on DEAE-Sephadex-A50 (Fig. 3). 
By comparison with the work of Ingebritsen et al. [34] we 
propose that peak I of H M G C o A reductase phosphatase is 
largely accounted for by PP-2C, with perhaps a small contri-
bution from PP-2Ai . However, in hepatocytes, H M G C o A 
reductase is markedly inactivated by okadaic acid treatment 
[12], ruling out a major role for PP-2C in the regulation of 
H M G C o A reductase in intact cells. Peak II of H M G C o A 
reductase phosphatase co-eluted with PP-2A2. Therefore, the 
H M G C o A reductase phosphatase activity in hepatocytes 
could result from both PP-2Ai in peak I and PP-2A2 in 
peak II. The H M G C o A reductase phosphatase expresses its 
activity in hepatocytes when A M P K is inactive. This is not the 
case for G A P P which requires glutamine. 
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